SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Eyenovia, Inc. (EYEN) , forward earnings yield 18.52%.
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
- Forward P/E 5.4
Overall SharesGrow Score: 34/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — EYEN
Valuation Multiples
P/E (TTM)0.0
Forward P/E5.4
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.00
Forward EPS (Est.)$1.40
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Forward Earnings Yield18.52%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$-0.36 |
$0.00 |
$-3.53M |
- |
| 2017 |
$-0.52 |
$0.00 |
$-5.13M |
- |
| 2018 |
$-1.82 |
$0.00 |
$-17.25M |
- |
| 2019 |
$-1.46 |
$0.00 |
$-20.99M |
- |
| 2020 |
$-0.94 |
$2M |
$-19.69M |
-984.6% |
| 2021 |
$-0.49 |
$14M |
$-12.99M |
-92.8% |
| 2022 |
$-0.82 |
$0.00 |
$-27.73M |
- |
| 2023 |
$-0.66 |
$3.79K |
$-27.26M |
-719859.9% |
| 2024 |
$-57.30 |
$57.34K |
$-49.82M |
-86888.6% |
| 2025 |
$0.00 |
$813.46M |
$-47B |
-5777.7% |
